临床试验/NCT04555187

NCT04555187已完成不适用

Cardiovascular Risk Stratification in Covid-19

Oregon Health and Science University1 个研究点分布在 1 个国家目标入组 1,355 人开始时间: 2020年6月8日最近更新: 2023年11月7日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Oregon Health and Science University
入组人数: 1,355
试验地点: 1
主要终点: Number and rate of persons with cardiovascular composite outcome

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This retrospective double-cohort study seeks to:

Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and
Develop a method of cardiovascular risk stratification in COVID-19

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 89 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•age >=18y
•available data on Covid19 test in the electronic medical record (either positive or negative)

排除标准

•no data of Covid19 test

结局指标

主要结局

Number and rate of persons with cardiovascular composite outcome

时间窗: 6 months after Covid19 test

Number and rate of persons with composite of all-cause death, critical care utilization (ICU bed), development of a life-threatening arrhythmia (ventricular tachycardia/ventricular fibrillation or sudden cardiac arrest), acute heart failure, myocardial infarction (STEMI, NSTEMI, or silent MI), or incident stroke, whichever comes first.

次要结局

Rate of all-cause death outcome(6 months after covid19 test)
Rate of cardiac arrhythmia(6 months after covid19 test)

研究者

发起方

Oregon Health and Science University

申办方类型

Other

责任方

Principal Investigator

主要研究者

Larisa Tereshchenko

Associate Professor of Medicine

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验

招募中

不适用

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)Heart Failure

NCT04983823Baker Heart and Diabetes Institute820

招募中

不适用

CardioVascular Disease Progression and Prognosis in COVID-19Covid19

NCT04606732University of Bologna2,000

Unknown

不适用

EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19Acute Myocardial Infarction

NCT04498091Centre Hospitalier Universitaire Dijon35

Unknown

不适用

Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19Covid19Myocardial InjuryCardiovascular DiseasesCardiovascular MorbidityHeart Failure

NCT04624503Humanitas Hospital, Italy500

Unknown

不适用

Myocardial Damage in COVID-19COVID-19Cardiovascular Diseases

NCT04312464Wuhan Union Hospital, China500